New Alzheimer’s Treatments and Dementia Centres Planned in Greece
Greek healthcare facilities have begun offering an innovative therapy to slow early-stage Alzheimer's progression, alongside plans to expand the national dementia support network.
- The new monoclonal antibody treatment, donanemab, targets early-stage Alzheimer's to slow cognitive decline.
- At least 35 patients have received the therapy across major Greek hospitals over the past year.
- Authorities are preparing to open 19 new integrated day care centres for dementia patients nationwide.
Residents in Greece or families supporting relatives with memory issues can consult specialist memory clinics in public hospitals or reach out to local neurologists. Information regarding regional support facilities is available via the Athens Alzheimer’s Association.
New Alzheimer’s Therapy Available in Greek Hospitals
The Greek healthcare system has introduced a new medical treatment designed to slow the progression of Alzheimer’s disease in eligible patients. According to medical experts, the therapy utilizes the monoclonal antibody donanemab, which targets beta-amyloid proteins in the brain and has received approval from Greece’s National Organisation for Medicines (EOF).
Over the past year, at least 35 patients have received the treatment at specialized hospitals in Athens, Patras, and Larissa. Access to the drug is managed through Greece’s Electronic Prior Approval System for specialized medications, requiring careful individual assessment by treating neurologists.
Patient Eligibility and Medical Safety
The treatment is restricted to individuals in the early stages of Alzheimer’s disease who meet specific medical criteria. Doctors evaluate patients thoroughly, excluding those with severe systemic illnesses, a history of certain strokes, or those taking specific anticoagulants. Regular brain monitoring through MRIs is required during the treatment process, which involves a monthly intravenous infusion.
Medical professionals stress that while the therapy is not a cure, clinical data suggest it can significantly slow cognitive and functional decline. Serious side effects remain infrequent, affecting a small percentage of patients under regular medical observation.
Expanding Greece’s Dementia Care Network
With an estimated 250,000 people living with dementia in Greece, authorities are working to strengthen the national support system. Plans are finalized to open 19 new integrated day care centres across the country to assist patients and their families.
Currently, dozens of memory clinics and day care facilities operate within Greek public and private hospitals. Individuals seeking guidance on local services and specialist support can contact the Athens Alzheimer’s Association or utilize the dedicated national dementia helpline.
